Objectives: Acinetobacter baumannii is a significant pathogen in health care settings. In recent years, an increase in carbapenem resistance among A. baumannii due to Ambler class B metallo-beta-lactamases or class D OXA carbapenamases has been reported. In this study we detected the presence of OXA carbapenamases and coproduction of metallo-beta-lactamases (bla VIM and bla IMP ) by phenotypic and genotypic methods in carbapenem resistant clinical isolates of Acinetobacter baumannii. Materials and Methods: A total of 116 consecutive, non-duplicate carbapenem resistant A. baumannii isolated from various clinical specimens were included in the study. The modified Hodge test and inhibitor potentiated disk diffusion tests were done for the screening of carbapenamase and metallo-beta-lactamase production, respectively. Polymerase chain reaction (PCR) was performed for the detection of OXA (bla OXA 23 like, bla OXA 24 like, bla OXA-51 like and bla OXA-58 like genes) and metallo-beta-lactamases (bla VIM and bla IMP ) genes. Gene sequencing was performed for representative isolates. Results: Among 116 A. baumannii, OXA genes were detected in 106 isolates. Bla OXA 51 like (n = 99) and bla OXA -23 like (n = 95) were the most common and they coexisted in 89 isolates. bla like gene was detected in two isolates of which one also carried bla OXA-51 like and bla OXA-58 like genes. The modified Hodge test was positive in 113 isolates. The metallo-beta-lactamase screening test was positive in 92 isolates. bla vim was detected in 54 isolates of which 1 also carried the bla IMP gene. Conclusions: bla OXA-23 like and bla OXA 51 like genes are the most common types of OXA carbapenamases while the bla VIM type is the most common type of metallo-beta-lactamase contributing to carbapenem resistance in clinical isolates of A. baumannii. The coproduction of OXA and metallo-betalactamases is not an uncommon phenomenon in A. baumannii.
Introduction
Multidrug resistant Acinetobacter baumannii is a significant pathogen in health care settings, where it causes a multitude of infections that include bacteremia, pneumonia, meningitis and urinary tract and wound infections. Its ability to survive under a wide range of environmental conditions makes it a frequent cause of outbreaks of infection and an endemic health careassociated pathogen. [1] A. baumannii is often resistant to a wide variety of antimicrobial agents, including carbapenems. Carbapenem resistance in A. baumannii is due to a variety of combined mechanisms such as hydrolysis by beta-lactamases, alterations in the outer membrane protein and penicillin-binding proteins and increased activity of efflux pumps. Acquired resistance to carbapenems, mediated by the Ambler class D beta-lactamases or OXAtype carbapenamases and Ambler class B metallo-betalactamases are of greatest concern as they are encoded by genes which are transmissible and account for most of the resistance to carbapenems. [2, 3] Carbapenem-hydrolyzing bla OXA-23 was first reported in A. baumannii in 1985. Since then several of them have been reported worldwide. Four families of OXA genes have been identified in A. baumannii: bla OXA-23 like (bla , bla and bla OXA-49 ); bla OXA-24 like (bla , bla , bla and bla OXA-40 ); bla OXA-58 and bla OXA-51 like. The last group constitutes a family of chromosomal enzymes typically present in A. baumannii. [2, 4, 5] Though the presence of bla OXA genes in A. baumannii is widely known, there is a paucity of information on the distribution of different types of OXA carbapenamases in isolates from the Indian subcontinent. [6] [7] [8] This study was undertaken to detect the prevalence of different bla OXA -type carbapenamases among nosocomial isolates of A. baumannii. The simultaneous presence of metallo-beta-lactamases (bla VIM and bla IMP ) type of carbapenamases was also determined in the study isolates. 
Materials and Methods

Bacterial strains
The study was conducted in a 1600-bedded university teaching hospital from April 2010 to October 2010. It included 116 clinically significant, non-duplicate, carbapenem resistant Acinetobacter baumannii recovered from clinical specimens of patients hospitalized for >48 h. The isolates were obtained from clinical specimens such as blood, cerebrospinal fluid, pus, wound swabs, and urine and lower respiratory secretions (bronchoalveolar lavage, bronchial wash and endotracheal secretions). The organisms were identified up to the species level using Microscan Walk Away 96, Gram-negative panels. Care was taken to differentiate commensals from pathogens for isolates obtained from nonsterile sites (respiratory tract, urinary tract, and wound swabs). The significance of the isolates was based on clinical history, presence of the organism in the Gram stain, presence of intracellular forms of the organism, and pure growth in culture with a significant colony count.
Antimicrobial susceptibility testing
Susceptibility to various classes of antibiotics was determined by the disc diffusion method in accordance with Clinical Laboratory Standard Institute (CLSI) guidelines.
[6] The antibiotics tested were amikacin (30 µg), ciprofloxacin (5 µg), ceftazidime (30 µg), piperacillintazobactam (100/10 µg), imipenem (10 µg), meropenem (10 µg) and polymyxin B (300 units), [9] from Himedia Laboratories (Mumbai, Maharashtra, India). Disc diffusion susceptibility testing was also performed for all the isolates using tigecycline disks (15 µg; BBL TM BD, USA). The interpretation of zone diameters was done using the United States Food and Administration's tigecycline susceptibility breakpoint criteria listed for Enterobacteriaceae (susceptible ³19 mm, intermediate 15--18 mm, resistance ≤14 mm). [10] MIC to imipenem and meropenem was done by the agar dilution method (range: 0.008-256 µg/ml) in accordance with CLSI guidelines. [9] 
Detection of carbapenamases
The detection of carbapenamases was done by the modified Hodge Test. Escherichia coli ATCC 25922 was cultured overnight and suspended to achieve a 0.5 McFarland standard turbidity and was lawn cultured onto a Mueller-Hinton agar plate using a sterile cotton swab. After drying, a disk containing imipenem (10 µg) was placed at the center of the plate, and an overnight cultured test strain was heavily streaked from the center to the periphery of the plate. The presence of a distorted zone after overnight incubation was interpreted as a positive result. [11] Though CLSI [9] does not advocate the use of the modified Hodge test for the detection of carbapenamase production in nonfermenting Gram-negative bacilli, several authors have found the modified Hodge test using imipenem as a useful screening test for carbapenamase production. [12] [13] [14] 
Detection of metallo-beta-lactamases
Zone enhancement with ethylenediaminetetraacetic acid (EDTA)-impregnated imipenem and ceftazidime discs Test organisms were inoculated on the plates with Mueller-Hinton agar. A 0.5 M EDTA solution was prepared by dissolving 186.1 g of disodium EDTA in 1000 ml of distilled water and adjusting its pH to 8.0. The EDTA solution was sterilized by autoclaving. Two 10-μg imipenem discs and two 30-μg ceftazidime discs were placed on the surface of the agar plate and EDTA solution (5 μl) was added to one of them to obtain a desired concentration of 750 μg. The inhibition zones of the imipenem and ceftazidime and their EDTA-impregnated discs were compared after incubation in air at 37°C. A zone size difference of ³7 mm was taken as indicative of metallobeta-lactamase production. [15] Detection of carbapenem resistance genes DNA template A 1:10 dilution of an overnight culture was boiled for 10 mins. Amplification was then performed with 10 µl of this dilution as the DNA template.
Multiplex PCR for the detection of OXA genes [5] Multiplex PCR was done for the detection of the four families of OXA-type carbapenamases found in A baumannii. Sequences of primers used for multiplex PCR for the detection of genes encoding bla OXA-23 like, bla OXA-24 like, bla OXA-51 like and bla OXA-58 like genes are given in Table 1 .
The PCR conditions were as follows: Initial denaturation at 94°C for 5 min, 33 cycles of 94°C for 25 s, 53°C for 40 s and 72°C for 50 s, followed by an elongation step at 72°C for 6 min.
The PCR products of 501 bp (bla OXA-23 like), 353 bp (bla OXA-51 like), 246 bp (bla OXA-24 like) and 599 bp (bla OXA-58 like) were visualized by agarose gel electrophoresis.
PCR for metallo-beta-lactamase genes: bla VIM and bla IMP [16] Primers used are given in Table 1 .
PCR conditions included 30 cycles of amplification under the following conditions: Denaturation at 95°C for 30 s, annealing for 1 min at specific temperatures (bla VIM , 66°C, and bla IMP , 45°C), and extension at 72°C for 1 min/kb product. Cycling was followed by a final extension at 72°C for 10 min. The PCR product of 500 bp (bla VIM ) and 432 bp (bla IMP ) was visualized by agarose gel electrophoresis.
DNA sequencing
The PCR products of representative isolates were then purified by using the PCR DNA purification kit (QIA Quick Gel Extraction Kit; Qiagen, Valencia, CA, USA) and subjected to automated DNA sequencing (ABI 3100, Genetic Analyser; Applied Biosystems, Foster City, CA, USA). The aligned sequences were then analysed with the Bioedit sequence program and similarity searches for the nucleotide sequences were performed with the BLAST program (http://www.ncbi.nlm.nih.gov).
Results
A. baumannii were isolated from clinical specimens such as blood (n = 25), respiratory secretions (n = 62), pus and wound swab (n = 18), cerebrospinal fluid (n = 4), body fluids (n = 3) and urine (n = 4). Most isolates were from patients in the intensive care units (ICU) of the health care facility (n = 111) and only 5 were from patients in the wards.
All of them were resistant to amikacin, ciprofloxacin, ceftazidime, piperacillin-tazobactam, imipenem and meropenem. The MIC to imipenem and meropenem ranged from 8 to 128 µg/ml. The MIC 50 and MIC 90 values for imipenem were 16 and 32 µg/ml, respectively. For meropenem, MIC 50 and MIC 90 values were 32 and 64 µg/ml, respectively.
Among the 116 isolates, 97.4% (n = 113) were susceptible to polymyxin and 93.1% (n = 108) to tigecycline.
Phenotypic tests
Of 116 A. baumannii, the modified Hodge test was positive for 113 (97.4%) of isolates [ Figure 1 ] while in 3, the test was negative. The metallo-beta-lactamase screening test with EDTA was positive in 92 (79.3%) isolates. like, bla OXA-24 like, bla OXA-51 like and bla OXA-58 like were detected in the majority (n = 106) of isolates [ Figure 2 ]. Most of them carried the bla OXA-51 like (n = 99) and bla OXA-23 like (n = 95) genes. Both coexisted in 89 isolates. Of the other OXA types, bla OXA-24 like was found only in two isolates, of which one also harboured bla OXA-51 like and bla OXA-58 like genes. The distribution of different types of OXA genes in the test organisms is given in Table 2 .
PCR bla
Among the modified Hodge test-positive A. baumannii (n = 113), OXA genes were not detected in seven isolates. Of them (n = 7), bla VIM was detected in four and the remaining three did not have bla OXA /bla VIM or bla IMP.
Regarding metallo-beta-lactamase, PCR detected bla VIM in 54 isolates, of which 1 carried both bla VIM and bla IMP [ Figures 3 and 4 ]. Of the above, 50 also harboured the OXA gene, particularly the bla OXA-23 like and bla OXA-51 like.
On review of the patient care areas from where the bla OXA -positive (n = 106) isolates were obtained, it was found that the multidisciplinary open ICU had the highest number of isolates carrying the bla OXA gene (69/74), followed by neurosurgery ICU (25/28), cardiothoracic ICU (6/7) and general wards (4/5). From the paediatric ICU, though the isolates obtained were only two, both carried the bla OXA gene.
Discussion
A. baumannii accounts for a substantial proportion of endemic nosocomial infections. Multidrug resistance increasingly reported in these pathogens is posing a threat to hospitalized patients due to the limitation of therapeutic options. The acquisition of multidrug resistance is related to environmental contamination and contact with transiently colonized health care providers. Carbapenems have been the drug of choice for treatment of infections caused by A. baumannii. However, in recent years, the number of isolates showing resistance to carbapenems has increased worldwide. [2, 12, 17] This is mediated by the lack of drug penetration (i.e. porin mutations and efflux pumps) and/or carbapenem-hydrolyzing beta-lactamase enzymes such as OXA carbapenamases and metallo-beta-lactamases. [2] The first identified OXA-type enzyme with carbapenemhydrolyzing activity was from an A. baumannii strain isolated in 1985 from Scotland and was originally named ARI-1, but was renamed as bla . The bla OXA-23 cluster (bla OXA-23,27,49 ) now contributes to carbapenem resistance in A. baumannii globally. Two other plasmid-encoded acquired OXA-type clusters with a carbapenamase activity have been described, which are bla OXA-24 -like (bla 25, 26, 40 ) and bla OXA-58 -like genes. The bla OXA-23 , bla OXA-24 and bla OXA-58 like enzymes are plasmid/chromosomally encoded which explains their widespread distribution. The bla OXA-51 like gene cluster is unique in that it naturally occurs in A.baumannii. Therefore it is chromosomally located and is widely prevalent. Similar to other class D enzymes, they have a greater affinity for imipenem than meropenem. Their role in carbapenem resistance is related to the presence of an insertion sequence ISAba1, situated upstream, possibly providing a promoter for the hyperproduction of beta-lactamase genes. [2, 18, 19] Strains that harbour multiple OXA encoding genes have been reported from several geographical areas. [12, 17, 20] In this study, overall OXA carbapenamases were A. baumannii infections, such resistance profiles limit therapeutic options to polymyxins and tigecycline. These drugs also have their own limitations and are not indicated as the drug of choice under a variety of clinical conditions. Easy and simple phenotypic tests are required for the early identification of carbapenamases in the clinical laboratories to notify the treating physicians and also devise methods to contain their spread.
Since the acquisition of multidrug resistant A. baumannii is related to environmental contamination and colonization in health care providers, control measures should address the source of infection. Continued careful attention to hand hygiene, contact isolation, barrier precautions, adequate environmental cleaning, and careful disinfection of patient care equipments along with surveillance are essential to prevent the outbreak of infections caused by these multidrug resistant strains. [21] To conclude, bla OXA-23 and bla OXA-51 are the most common types of OXA carbapenamases in A. baumannii. This type of resistance is a factor with a significant threat in hospitals. It should be addressed with alternative and newer therapeutic strategies, strict infection control measures and continuous surveillance. A simultaneous existence of different classes of carbapenamases is a problem to reckon with and hence detection methods are required for each of these. In outbreak settings, an initial screening of the putative carbapenamase producers will help to organize intervention and early directed therapy.
In four carbapenem resistant A. baumannii, bla VIM was detected without the OXA genes. Among the modified Hodge test-positive isolates (n = 113), PCR for OXA, bla VIM and bla IMP was negative in three isolates suggesting the presence of other carbapenamases.
For the carbapenem resistant isolates which were modified Hodge test-negative (n = 3), it may be assumed to be due to the presence of porin mutations and upregulation of efflux pumps.
Among the 116 study isolates, 97.4% (n = 113) were susceptible to polymyxin and 93.1% (n = 108) to tigecycline. The lack of universal susceptibility to these two drugs is a cause for concern. All the study isolates were uniformly resistant to aminoglycosides and fluoroquinolones.
Though carbapenems are the drug of choice to treat
